Drug: NOVORAPID Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 9 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
91999823 | NOVORAPID | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | M | 0 | 20160826 | CH |
124204854 | NOVORAPID | Foetal exposure during pregnancy | AVENTIS | 0.00 | M | 5 KG | 20160921 | DK |
125286131 | NOVORAPID | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | M | 3 KG | 20160705 | ZA |
125462972 | NOVORAPID | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | M | 3 KG | 20160824 | AZ |
125496491 | NOVORAPID | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | F | 0 | 20160712 | AZ |
125878971 | NOVORAPID | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | M | 0 | 20160725 | GB |
126773431 | NOVORAPID | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | F | 2 KG | 20160823 | PL |
127047461 | NOVORAPID | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | M | 4 KG | 20160831 | TR |
127365151 | NOVORAPID | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | F | 0 | 20160912 | HN |
Total Records: 9 Number of Pages: 1